Jonathan Fauerbach (Ph.D.

Jonathan Fauerbach (PhD, MBA) currently serves as the Head of Research and Development at LenioBio, where responsibilities include leading innovations and strategic advancements of the ALiCE® platform for protein expression. Previous experience includes roles as Business Segment Leader for Cell Separation at Miltenyi Biotec, where Jonathan drove strategic and global growth initiatives, and a postdoctoral research fellowship at Stanford University focused on Huntington's disease research. Jonathan Fauerbach's academic credentials feature a PhD in Organic Chemistry from the University of Buenos Aires, as well as dual MBA degrees from the Rotterdam School of Management and University of Cologne Business School.